(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|---|
Turnover | --318.97B | 10.28%218.12B | 8.10%373.71B | 7.69%197.8B | 0.68%345.71B | --183.66B | 20.18%343.36B | --285.71B |
Special items of operating revenue | --1.38B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Operating income | 320.35B | 10.28%218.12B | 8.10%373.71B | 7.69%197.8B | 0.68%345.71B | 183.66B | 20.18%343.36B | 285.71B |
Cost of sales | ---- | -7.60%-159.63B | -4.96%-275.32B | -4.98%-148.35B | 1.55%-262.32B | ---141.32B | -21.86%-266.45B | ---218.65B |
Operating expenses | -233.63B | -7.60%-159.63B | -4.96%-275.32B | -4.98%-148.35B | 1.55%-262.32B | -141.32B | -21.86%-266.45B | -218.65B |
Gross profit | 86.72B | 18.30%58.49B | 17.99%98.39B | 16.76%49.44B | 8.42%83.39B | 42.35B | 14.70%76.91B | 67.06B |
Selling expenses | ---31.16B | -25.23%-21.46B | -21.47%-34.88B | -16.57%-17.13B | -0.24%-28.72B | ---14.7B | -21.58%-28.65B | ---23.56B |
Administrative expenses | ---10.36B | -17.96%-6.96B | -16.23%-13.98B | -13.95%-5.9B | -11.93%-12.02B | ---5.18B | -10.52%-10.74B | ---9.72B |
Research and development expenses | ---11.4B | -15.85%-7.66B | -15.15%-14.59B | -12.65%-6.61B | -5.43%-12.67B | ---5.87B | -17.85%-12.01B | ---10.19B |
Profit from asset sales | --258.26M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Revaluation surplus | --328.54M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Changes in the fair value of other assets | --328.54M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provision | ---486.22M | 83.94%-35.21M | 56.33%-235M | -1.25%-219.21M | -39.95%-538.11M | ---216.51M | -28.27%-384.5M | ---299.76M |
-Other impairment is provision | ---486.22M | 83.94%-35.21M | 56.33%-235M | -1.25%-219.21M | -39.95%-538.11M | ---216.51M | -28.27%-384.5M | ---299.76M |
Operating interest expense | ---1.82M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Special items of operating profit | --2.93B | -26.16%2.82B | 19.11%7.17B | 43.54%3.81B | -32.73%6.02B | --2.66B | -0.29%8.95B | --8.98B |
Operating profit | 35.19B | 7.71%25.19B | 18.10%41.89B | 22.85%23.39B | 4.08%35.47B | 19.04B | 5.63%34.08B | 32.26B |
Financing income | ---- | 47.77%697.28M | 36.82%1.09B | 63.08%471.86M | 97.55%793.18M | --289.34M | 8.04%401.5M | --371.63M |
Financing cost | --2.98B | 58.72%-866.07M | -77.29%-3.37B | -178.62%-2.1B | -46.39%-1.9B | ---752.93M | 5.63%-1.3B | ---1.38B |
Share of profits of associates | ---- | 23.93%431.94M | 11.92%680.76M | 32.52%348.55M | 8.49%608.28M | --263.01M | 39.29%560.68M | --402.53M |
Special items of earning before tax | --224.45M | ---- | ---- | ---- | ---6.18M | ---- | ---- | ---- |
Earning before tax | 38.4B | 15.12%25.45B | 15.22%40.28B | 17.38%22.11B | 3.62%34.96B | 18.83B | 6.58%33.74B | 31.66B |
Tax | ---6.25B | -20.45%-4.31B | -26.93%-6.53B | -32.01%-3.58B | -9.33%-5.15B | ---2.71B | -13.28%-4.71B | ---4.16B |
After-tax profit from continuing operations | 32.15B | 14.10%21.14B | 13.20%33.75B | 14.92%18.53B | 2.69%29.81B | 16.12B | 5.56%29.03B | 27.5B |
Earning after tax | 32.15B | 14.10%21.14B | 13.20%33.75B | 14.92%18.53B | 2.69%29.81B | 16.12B | 5.56%29.03B | 27.5B |
Minority profit | --451.87M | 13.66%337.08M | -90.18%25.42M | 130.08%296.56M | -41.77%258.78M | --128.89M | 59.44%444.45M | --278.76M |
Profit attributable to shareholders | 31.7B | 14.10%20.8B | 14.10%33.72B | 13.99%18.23B | 3.38%29.55B | 15.99B | 5.01%28.59B | 27.22B |
Basic earnings per share | 4.58 | 13.11%3.02 | 13.59%4.93 | 14.10%2.67 | 4.08%4.34 | 2.34 | 6.11%4.17 | 3.93 |
Diluted earnings per share | 4.57 | 13.16%3.01 | 13.63%4.92 | 13.68%2.66 | 4.59%4.33 | 2.34 | 6.15%4.14 | 3.9 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data